These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8544011)

  • 1. Estimation of neocortical serotonin-2 receptor binding potential by single-dose fluorine-18-setoperone kinetic PET data analysis.
    Petit-Taboué MC; Landeau B; Osmont A; Tillet I; Barré L; Baron JC
    J Nucl Med; 1996 Jan; 37(1):95-104. PubMed ID: 8544011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parametric PET imaging of 5HT2A receptor distribution with 18F-setoperone in the normal human neocortex.
    Petit-Taboué MC; Landeau B; Barré L; Onfroy MC; Noël MH; Baron JC
    J Nucl Med; 1999 Jan; 40(1):25-32. PubMed ID: 9935052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY-100635 in humans: comparison of arterial and reference tisssue input functions.
    Parsey RV; Slifstein M; Hwang DR; Abi-Dargham A; Simpson N; Mawlawi O; Guo NN; Van Heertum R; Mann JJ; Laruelle M
    J Cereb Blood Flow Metab; 2000 Jul; 20(7):1111-33. PubMed ID: 10908045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomographic analysis of central 5-hydroxytryptamine2 receptor occupancy in healthy volunteers treated with the novel antipsychotic agent, ziprasidone.
    Fischman AJ; Bonab AA; Babich JW; Alpert NM; Rauch SL; Elmaleh DR; Shoup TM; Williams SA; Rubin RH
    J Pharmacol Exp Ther; 1996 Nov; 279(2):939-47. PubMed ID: 8930203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A method for the in vivo investigation of the serotonergic 5-HT2 receptors in the human cerebral cortex using positron emission tomography and 18F-labeled setoperone.
    Blin J; Sette G; Fiorelli M; Bletry O; Elghozi JL; Crouzel C; Baron JC
    J Neurochem; 1990 May; 54(5):1744-54. PubMed ID: 2182776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicompartmental study of fluorine-18 altanserin binding to brain 5HT2 receptors in humans using positron emission tomography.
    Biver F; Goldman S; Luxen A; Monclus M; Forestini M; Mendlewicz J; Lotstra F
    Eur J Nucl Med; 1994 Sep; 21(9):937-46. PubMed ID: 7995287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling [18 F]MPPF positron emission tomography kinetics for the determination of 5-hydroxytryptamine(1A) receptor concentration with multiinjection.
    Costes N; Merlet I; Zimmer L; Lavenne F; Cinotti L; Delforge J; Luxen A; Pujol JF; Le Bars D
    J Cereb Blood Flow Metab; 2002 Jun; 22(6):753-65. PubMed ID: 12045674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [18F]setoperone: a new high-affinity ligand for positron emission tomography study of the serotonin-2 receptors in baboon brain in vivo.
    Blin J; Pappata S; Kiyosawa M; Crouzel C; Baron JC
    Eur J Pharmacol; 1988 Feb; 147(1):73-82. PubMed ID: 3259509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicompartmental analysis of [11C]-carfentanil binding to opiate receptors in humans measured by positron emission tomography.
    Frost JJ; Douglass KH; Mayberg HS; Dannals RF; Links JM; Wilson AA; Ravert HT; Crozier WC; Wagner HN
    J Cereb Blood Flow Metab; 1989 Jun; 9(3):398-409. PubMed ID: 2541148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-cerebrospinal fluid and blood-brain barriers imaged by 18F-labeled metabolites of 18F-setoperone studied in humans using positron emission tomography.
    Blin J; Crouzel C
    J Neurochem; 1992 Jun; 58(6):2303-10. PubMed ID: 1573409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability of a simple non-invasive method for the evaluation of 5-HT2 receptors using [18F]-setoperone PET imaging.
    Kapur S; Jones C; DaSilva J; Wilson A; Houle S
    Nucl Med Commun; 1997 May; 18(5):395-9. PubMed ID: 9194079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography quantification of [11C]-(+)-PHNO binding in the human brain.
    Ginovart N; Willeit M; Rusjan P; Graff A; Bloomfield PM; Houle S; Kapur S; Wilson AA
    J Cereb Blood Flow Metab; 2007 Apr; 27(4):857-71. PubMed ID: 17033687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.
    Smith GS; Price JC; Lopresti BJ; Huang Y; Simpson N; Holt D; Mason NS; Meltzer CC; Sweet RA; Nichols T; Sashin D; Mathis CA
    Synapse; 1998 Dec; 30(4):380-92. PubMed ID: 9826230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simplified reference region model for the kinetic analysis of [99mTc]TRODAT-1 binding to dopamine transporters in nonhuman primates using single-photon emission tomography.
    Acton PD; Kushner SA; Kung MP; Mozley PD; Plössl K; Kung HF
    Eur J Nucl Med; 1999 May; 26(5):518-26. PubMed ID: 10382097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic evaluation of [11C]dihydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporter.
    Koeppe RA; Frey KA; Vander Borght TM; Karlamangla A; Jewett DM; Lee LC; Kilbourn MR; Kuhl DE
    J Cereb Blood Flow Metab; 1996 Nov; 16(6):1288-99. PubMed ID: 8898703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of striatal and extrastriatal dopamine D1 receptor binding potential with [11C]NNC 112 in humans: validation and reproducibility.
    Abi-Dargham A; Martinez D; Mawlawi O; Simpson N; Hwang DR; Slifstein M; Anjilvel S; Pidcock J; Guo NN; Lombardo I; Mann JJ; Van Heertum R; Foged C; Halldin C; Laruelle M
    J Cereb Blood Flow Metab; 2000 Feb; 20(2):225-43. PubMed ID: 10698059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET measurement of D2 and S2 receptor binding of 3-N-[( 2'-18F]fluoroethyl)spiperone in baboon brain.
    Coenen HH; Wienhard K; Stöcklin G; Laufer P; Hebold I; Pawlik G; Heiss WD
    Eur J Nucl Med; 1988; 14(2):80-7. PubMed ID: 2968911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of serotonergic transporters using PET and [11C](+)McN-5652: assessment of methods.
    Buck A; Gucker PM; Schönbächler RD; Arigoni M; Kneifel S; Vollenweider FX; Ametamey SM; Burger C
    J Cereb Blood Flow Metab; 2000 Feb; 20(2):253-62. PubMed ID: 10698061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling alternatives for cerebral carbon-11-iomazenil kinetics.
    Buck A; Westera G; vonSchulthess GK; Burger C
    J Nucl Med; 1996 Apr; 37(4):699-705. PubMed ID: 8691270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the quantification of [18F]MPPF binding to 5-HT1A receptors in the human brain.
    Passchier J; van Waarde A; Vaalburg W; Willemsen AT
    J Nucl Med; 2001 Jul; 42(7):1025-31. PubMed ID: 11438622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.